Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-023109

Vitae Pharmaceuticals, Inc · VTAE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
David Schnell
10% Owner
Period of report
Mar 24, 2015
Accepted (ET)
Mar 26, 2015 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Mar 24, 2015J900,383$0.00D1,672,140ISee Footnote
Common StockF4,F5Mar 24, 2015J20,357$0.00A32,584ISee Footnote
Common StockF7,F8Mar 24, 2015J20,357$0.00A28,237ISee Footnote
Common StockF9holding———395,799ISee Footnote
Common StockF10,F11holding———0ISee Footnote
Common StockF12,F13holding———0ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses